IDEAYA Biosciences, Inc. (IDYA) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 3.48B USD. 52-week range 26.05 to 42.68 USD. Data as of 2026-10-09.
IDEAYA Biosciences, Inc., a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company offers Darovasertib, an oral, potent, and selective protein kinase, C (PKC) inhibitor for the treatment of uveal melanoma, ocular cancer, and is being evaluated in multiple clinical trials as monotherapy and in combination with crizotinib for metastatic, neoadjuvant, and adjuvant settings. The company also ...